Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells
Background Relapsed/refractory B-precursor acute lymphoblastic leukemia (BCP-ALL) remains a major therapeutic challenge in pediatric hematology. Chimeric antigen receptor (CAR) T cells targeting CD19 have shown remarkable initial response rates in BCP-ALL patients, while long-term leukemia control r...
Saved in:
| Main Authors: | Armin Wolf, Semjon Willier, Johannes Raedler, Franziska Blaeschke, Dana Stenger, Montserrat Pazos Escudero, Florian Jurgeleit, Thomas G P Grünewald, Vera Binder, Irene Schmid, Michael H Albert, Tobias Feuchtinger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e001052.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin’s lymphoma
by: Eva Fernández Cañabate, et al.
Published: (2018-01-01) -
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults
by: Maike Breidenbach, et al.
Published: (2025-01-01) -
Study on the Design of Tall Building Escape Device based on Escapement Mechanism
by: Zhang Liping
Published: (2016-01-01) -
Thermally Driven Atmospheric Escape: Transition from Diffusion-limited to Drag-off Escape
by: Jack C. Evans, et al.
Published: (2025-01-01) -
In love with the desert
by: R. Wheeler
Published: (2022-06-01)